BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giacomini I, Gianfanti F, Desbats MA, Orso G, Berretta M, Prayer-Galetti T, Ragazzi E, Cocetta V. Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy. Front Oncol 2021;11:682911. [PMID: 34109128 DOI: 10.3389/fonc.2021.682911] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Samec M, Mazurakova A, Lucansky V, Koklesova L, Pecova R, Pec M, Golubnitschaja O, Al-Ishaq RK, Caprnda M, Gaspar L, Prosecky R, Gazdikova K, Adamek M, Büsselberg D, Kruzliak P, Kubatka P. Flavonoids attenuate cancer metabolism by modulating Lipid metabolism, amino acids, ketone bodies and redox state mediated by Nrf2. Eur J Pharmacol 2023;:175655. [PMID: 36921709 DOI: 10.1016/j.ejphar.2023.175655] [Reference Citation Analysis]
2 Tanriver G, Kocagoncu E. Additive pre-diagnostic and diagnostic value of routine blood-based biomarkers in the detection of colorectal cancer in the UK Biobank cohort. Sci Rep 2023;13:1367. [PMID: 36693981 DOI: 10.1038/s41598-023-28631-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang X, Sun C, Wan J, Zhang X, Jia Y, Zhou C. Compartmentalized activities of HMGCS1 control cervical cancer radiosensitivity. Cell Signal 2023;101:110507. [PMID: 36328117 DOI: 10.1016/j.cellsig.2022.110507] [Reference Citation Analysis]
4 Hwang HJ, Lee KH, Cho JY. ABCA9, an ER cholesterol transporter, inhibits breast cancer cell proliferation via SREBP-2 signaling. Cancer Sci 2022. [PMID: 36576228 DOI: 10.1111/cas.15710] [Reference Citation Analysis]
5 Abdul Rashid K, Ibrahim K, Wong JHD, Mohd Ramli N. Lipid Alterations in Glioma: A Systematic Review. Metabolites 2022;12. [PMID: 36557318 DOI: 10.3390/metabo12121280] [Reference Citation Analysis]
6 Halimi H, Farjadian S. Cholesterol: An important actor on the cancer immune scene. Front Immunol 2022;13:1057546. [PMID: 36479100 DOI: 10.3389/fimmu.2022.1057546] [Reference Citation Analysis]
7 Samec M, Mazurakova A, Lucansky V, Koklesova L, Pecova R, Pec M, Golubnitschaja O, Al-ishaq RK, Caprnda M, Gaspar L, Prosecky R, Gazdikova K, Adamek M, Büsselberg D, Kruzliak P, Kubatka P. Flavonoids Attentuate Cancer Metabolism by Modulating Redox State, lipid metabolism, and use of amino acids or ketone bodies.. [DOI: 10.21203/rs.3.rs-2273746/v1] [Reference Citation Analysis]
8 Peng L, Yan Q, Chen Z, Hu Y, Sun Y, Miao Y, Wu Y, Yao Y, Tao L, Chen F, Li H, Xu T. Research progress on the role of cholesterol in hepatocellular carcinoma. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175410] [Reference Citation Analysis]
9 Kant R, Manne RK, Anas M, Penugurti V, Chen T, Pan BS, Hsu CC, Lin HK. Deregulated transcription factors in cancer cell metabolisms and reprogramming. Semin Cancer Biol 2022;86:1158-74. [PMID: 36244530 DOI: 10.1016/j.semcancer.2022.10.001] [Reference Citation Analysis]
10 Ediriweera MK. Use of cholesterol metabolism for anti-cancer strategies. Drug Discov Today 2022;27:103347. [PMID: 36087905 DOI: 10.1016/j.drudis.2022.103347] [Reference Citation Analysis]
11 Guha A, Stabellini N, Montero AJ. Commentary: Longitudinal changes in circulating metabolites and lipoproteins after breast cancer treatment. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.962698] [Reference Citation Analysis]
12 Tang L, Wei R, Chen R, Fan G, Zhou J, Qi Z, Wang K, Wei Q, Wei X, Xu X. Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.07.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Maja M, Mohammed D, Dumitru AC, Verstraeten S, Lingurski M, Mingeot-Leclercq MP, Alsteens D, Tyteca D. Surface cholesterol-enriched domains specifically promote invasion of breast cancer cell lines by controlling invadopodia and extracellular matrix degradation. Cell Mol Life Sci 2022;79:417. [PMID: 35819726 DOI: 10.1007/s00018-022-04426-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Centonze G, Natalini D, Piccolantonio A, Salemme V, Morellato A, Arina P, Riganti C, Defilippi P. Cholesterol and Its Derivatives: Multifaceted Players in Breast Cancer Progression. Front Oncol 2022;12:906670. [PMID: 35719918 DOI: 10.3389/fonc.2022.906670] [Reference Citation Analysis]
15 Halámková J, Bohovicová L, Pehalová L, Goněc R, Staněk T, Kazda T, Mouková L, Krákorová DA, Kozáková Š, Svoboda M, Demlová R, Kiss I. Use of Hypolipidemic Drugs and the Risk of Second Primary Malignancy in Colorectal Cancer Patients. Cancers 2022;14:1699. [DOI: 10.3390/cancers14071699] [Reference Citation Analysis]
16 Pan Z, Wang K, Wang X, Jia Z, Yang Y, Duan Y, Huang L, Wu ZX, Zhang JY, Ding X. Cholesterol promotes EGFR-TKIs resistance in NSCLC by inducing EGFR/Src/Erk/SP1 signaling-mediated ERRα re-expression. Mol Cancer 2022;21:77. [PMID: 35303882 DOI: 10.1186/s12943-022-01547-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
17 Allen CNS, Arjona SP, Santerre M, Sawaya BE. Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis. Viruses 2022;14:602. [DOI: 10.3390/v14030602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kosaka S, Miyashita M, Mcnamala K, Nomura M, Shima H, Kawai M, Sato I, Shoji-harada N, Ishida T, Choi MH, Sasano H. Bird’s eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes. The Journal of Steroid Biochemistry and Molecular Biology 2022. [DOI: 10.1016/j.jsbmb.2022.106103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kovacs T, Zakany F, Nagy P. It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases. Cancers (Basel) 2022;14:944. [PMID: 35205690 DOI: 10.3390/cancers14040944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
20 Chen PH, Jhou HJ, Chung CH, Lee CH, Wu YY, Chang WC, Chien WC, Chang PY. The Effect of Statins in Cancer Risk Reduction in Patients on Dialysis: A Population-Based Case-Control Study. J Clin Med 2021;10:5602. [PMID: 34884304 DOI: 10.3390/jcm10235602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Mangelinck A, Habel N, Mohr A, Gaspar N, Stefanovska B, Fromigué O. Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma. Cancers (Basel) 2021;13:5869. [PMID: 34831022 DOI: 10.3390/cancers13225869] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Chen Y, Lee K, Liang Y, Qin S, Zhu Y, Liu J, Yao S. A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration. Front Genet 2021;12:763537. [PMID: 34790227 DOI: 10.3389/fgene.2021.763537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Kumar N, Mandal CC. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis. Front Genet 2021;12:724149. [PMID: 34603386 DOI: 10.3389/fgene.2021.724149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Škara L, Huđek Turković A, Pezelj I, Vrtarić A, Sinčić N, Krušlin B, Ulamec M. Prostate Cancer-Focus on Cholesterol. Cancers (Basel) 2021;13:4696. [PMID: 34572923 DOI: 10.3390/cancers13184696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]